STEVEN DUFFY, MD
Internal Medicine Physician · EAST SYRACUSE, NY
Individual Active NPI 1154586188
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 882 | 167,004 | $7,162,889 | $3,475,304 | $2,776,112 |
| 2023 | 897 | 155,852 | $5,670,039 | $2,562,229 | $2,046,041 |
| 2022 | 821 | 158,654 | $6,318,781 | $2,724,704 | $2,175,460 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1439 | Injection, ferric carboxymaltose, 1 mg | 20,500 | $1 | $1 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 17,037 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 12,000 | $56 | $45 |
| J9299 | Injection, nivolumab, 1 mg | 11,736 | $31 | $25 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 9,245 | $3 | $2 |
| J9025 | Injection, azacitidine, 1 mg | 7,600 | $0 | $0 |
| J0185 | Injection, aprepitant, 1 mg | 7,150 | $2 | $1 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 5,040 | $49 | $39 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 4,171 | $0 | $0 |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 4,160 | $47 | $37 |
| J0897 | Injection, denosumab, 1 mg | 3,540 | $25 | $20 |
| J1930 | Injection, lanreotide, 1 mg | 2,520 | $48 | $38 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Internal Medicine Physician | 207R00000X | ✓ | 251381 | NY |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Internal Medicine Physician providers in New York
- NPI 1417948928
- NPI 1467793273
- NPI 1275583486
- NPI 1942461256
- NPI 1598748956
- NPI 1902896012
- NPI 1750371548
- NPI 1831505643
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.